SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE5105.00-10.1 (-0.2 %)
PREV CLOSE ( ) 5115.10
OPEN PRICE ( ) 5092.55
BID PRICE (QTY) 5102.45 (3)
OFFER PRICE (QTY) 5131.80 (8)
VOLUME 137
TODAY'S LOW / HIGH ( )5092.55 5139.40
52 WK LOW / HIGH ( )4360.3 5954
NSE5110.0012.5 (+0.25 %)
PREV CLOSE( ) 5097.50
OPEN PRICE ( ) 5088.50
BID PRICE (QTY) 5110.50 (1)
OFFER PRICE (QTY) 5118.50 (1)
VOLUME 540
TODAY'S LOW / HIGH( ) 5076.00 5135.00
52 WK LOW / HIGH ( )4211.55 5894.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 10-05 2023
Management Info
Amit Jain - Chairman Himanshu Bakshi - Managing Director
Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
05Aug Sanofi Consumer Healthcare India repor
Sanofi Consumer Healthcare India has reported result for second quarter..
05Aug Sanofi Consumer Healthcare India zooms
Sanofi Consumer Healthcare India is currently trading at Rs. 5319.55, up..
13Jun Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the exchange has rece..
26May Post-Offer Advertisement
Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has su..
11Apr Sanofi Consumer Healthcare India infor
Pursuant to Regulation 26(7) of the SEBI (Substantial Acquisition of Sha..
Financials
Rs. in Millions
QTR Jun 25 ANNUAL 24
Net Profit6071810
Gross Profit 789 2468
Operating Profit 7582836
Net Sales 22097245
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 14205.60 (3.61%)
M.Cap ( in Cr)18143.52
Abbott India (BSE)
 32770.00 (1.28%)
M.Cap ( in Cr)68946.55
Astrazeneca Pharma I (BSE)
 9081.55 (1.61%)
M.Cap ( in Cr)22648.75
Glenmark Pharma (BSE)
 2004.00 (4.44%)
M.Cap ( in Cr)56493.78
Ajanta Pharma (BSE)
 2554.35 (3.05%)
M.Cap ( in Cr)32162.80
Shareholding Pattern
PROMOTERS 71.27%
MUTUAL FUNDS/UTI 12.85%
NON-INSTITUTION 8.6%
FI/BANKS/INSURANCE 4.02%
GOVERNMENT 0%
FII 0%

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by  Accord Fintech Pvt. Ltd.